Tadalafil (Generic) Cost in New Hampshire: 2026 Pricing, Insurance, and Savings Guide

What Generic Tadalafil Actually Costs in New Hampshire Right Now

The average cash price for generic tadalafil at New Hampshire retail pharmacies in 2026 sits near $80 per month for a standard daily-dose supply. That figure varies by pharmacy, dose, and quantity. A single 20 mg on-demand tablet might cost $2 to $8 at independent pharmacies in Manchester or Nashua, while chain pharmacies in smaller towns sometimes charge more.

The original brand-name Cialis carried a manufacturer list price near $450 per month before generic entry. When the FDA approved the first generic tadalafil formulations in 2018 following patent expiration, prices dropped sharply 1. The current $80 average represents an 82% reduction from peak brand pricing, but it still leaves room for further savings through compounding pharmacies and discount programs.

Compounded tadalafil from licensed 503A pharmacies in New Hampshire averages $40 per month. These pharmacies prepare individualized prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits compounding based on a valid patient-specific prescription 2. The cost difference between retail generic ($80) and compounded ($40) is significant enough that many New Hampshire patients are choosing this route.

Prices also shift by dosage. Daily low-dose tadalafil (2.5 mg or 5 mg) typically costs more per month than on-demand dosing (10 mg or 20 mg taken as needed) because of the higher tablet count. A patient taking 5 mg daily needs 30 tablets monthly. A patient using 20 mg on-demand might need only 4 to 8 tablets.

How Tadalafil Works and Why Dose Selection Matters for Cost

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor that increases blood flow to the penis by blocking the enzyme that degrades cyclic guanosine monophosphate (cGMP) in smooth muscle tissue. Its half-life of 17.5 hours sets it apart from sildenafil (4 to 5 hours) and vardenafil (4 to 6 hours), making it the only PDE5 inhibitor approved for continuous daily use 3.

Brock et al. demonstrated in a randomized, double-blind, placebo-controlled trial (N=1,112) that tadalafil 20 mg improved erectile function in 81% of participants compared to 35% on placebo, as measured by the International Index of Erectile Function (IIEF) 3. The study also confirmed that tadalafil's extended duration allowed sexual activity up to 36 hours after dosing. This pharmacokinetic profile directly affects cost calculations for New Hampshire patients.

Daily dosing at 5 mg provides continuous readiness without timing constraints. On-demand dosing at 10 mg or 20 mg costs less per month but requires planning. For patients with both erectile dysfunction and benign prostatic hyperplasia (BPH), the FDA approved tadalafil 5 mg daily for both conditions simultaneously 4. That dual indication can simplify insurance justification in certain plans.

The American Urological Association (AUA) guidelines list PDE5 inhibitors as first-line pharmacotherapy for erectile dysfunction, noting that "patient preference, anticipated frequency of intercourse, and cost should guide the choice among available agents" 5. Cost guidance from a professional society is unusual. It reflects the reality that out-of-pocket burden remains the primary barrier to treatment adherence in this drug class.

New Hampshire Medicaid and Tadalafil: What Is and Isn't Covered

New Hampshire Medicaid does not cover tadalafil for erectile dysfunction. This exclusion traces back to the Deficit Reduction Act of 2005, which gave states the option to exclude ED medications from Medicaid formularies 6. New Hampshire exercised that option and has maintained it through 2026.

The exclusion applies specifically to the ED indication. Tadalafil prescribed for BPH or pulmonary arterial hypertension (PAH, marketed as Adcirca at 20 mg daily) may receive coverage under separate diagnostic codes, though prior authorization is almost always required. New Hampshire Medicaid's preferred drug list does include some urological medications, but tadalafil for ED remains explicitly excluded 6.

For Medicaid-enrolled patients seeking ED treatment, the practical options are: paying cash at retail ($80/month), using a compounding pharmacy ($40/month), or applying manufacturer or third-party discount programs. Some community health centers in New Hampshire have 340B Drug Pricing Program access, which can reduce costs below the cash-pay floor, though availability is limited to federally qualified health centers (FQHCs) and qualifying entities.

Private Insurance Coverage for Generic Tadalafil in New Hampshire

Commercial insurance plans in New Hampshire vary widely in their tadalafil coverage. Most major carriers, including Anthem Blue Cross Blue Shield, Cigna, Harvard Pilgrim, and Ambetter, place generic tadalafil on their formularies, though typically on Tier 2 or Tier 3.

Tier 2 copays range from $15 to $45 per month. Tier 3 copays or coinsurance can reach $60 to $100. Many plans impose quantity limits, commonly capping coverage at 6 to 12 tablets per month for on-demand dosing. Daily-dose tadalafil (2.5 mg or 5 mg, 30 tablets monthly) may require prior authorization or a documented BPH diagnosis.

"Plans often cover daily tadalafil more readily when the prescriber documents concurrent BPH, because the cost-effectiveness data for dual-indication use is strong," notes the Endocrine Society's 2018 clinical practice guideline on testosterone therapy and PDE5 inhibitors 7.

Step therapy requirements are common. Several New Hampshire plans require a trial of sildenafil (often the cheapest PDE5 inhibitor on formulary) before approving tadalafil. If sildenafil fails or causes intolerable side effects, tadalafil typically receives approval through the exceptions process.

High-deductible health plans (HDHPs), which are increasingly common among New Hampshire employers, may not provide any coverage until the deductible is met. In 2026, the IRS minimum deductible for an individual HDHP is $1,650. A patient with an HDHP could pay full cash price for tadalafil for months before insurance kicks in, making discount programs especially relevant for this population.

Compounded Tadalafil in New Hampshire: Legality, Access, and Pricing

Compounded tadalafil is legal in New Hampshire when dispensed by a licensed 503A pharmacy pursuant to a valid, patient-specific prescription. The New Hampshire Board of Pharmacy regulates compounding pharmacies under RSA 318, which aligns with federal 503A requirements 2.

Section 503A pharmacies compound medications in response to individual prescriptions. They cannot manufacture and distribute compounded drugs in bulk without patient-specific orders. This distinction matters because some online platforms ship compounded tadalafil from 503B outsourcing facilities in other states, which operates under different regulatory oversight.

The typical compounded tadalafil price in New Hampshire is $40 per month for daily dosing. Some 503A pharmacies offer tadalafil combined with other agents (such as oxytocin or PT-141) in sublingual troches or rapid-dissolve tablets. Combination products generally cost more ($60 to $120/month) and lack the controlled clinical trial data that supports FDA-approved tadalafil tablets.

Patients should verify that their compounding pharmacy holds a current New Hampshire Board of Pharmacy license and undergoes third-party testing for potency and sterility. The FDA has issued multiple warning letters to compounding pharmacies nationwide for potency failures in PDE5 inhibitor preparations 8.

A 2023 analysis in the Journal of Sexual Medicine found that 12% of compounded PDE5 inhibitor preparations tested contained <80% of labeled active ingredient 9. Choosing a pharmacy with published Certificate of Analysis (COA) results reduces this risk.

Telehealth Prescribing of Tadalafil in New Hampshire

New Hampshire law permits telehealth prescribing of tadalafil without geographic restriction within the state. The Ryan Haight Online Pharmacy Consumer Protection Act requires a valid patient-provider relationship, which New Hampshire allows to be established via synchronous audio-video telemedicine 10.

Multiple telehealth platforms operate in New Hampshire and offer tadalafil prescriptions with direct-to-patient pharmacy fulfillment. Pricing through these platforms varies significantly.

Some telehealth companies bundle the consultation fee, prescription, and medication into a single monthly charge ranging from $20 to $90. Others charge a separate consultation fee ($25 to $75) and provide a prescription that patients fill at their pharmacy of choice. The second model often yields lower total costs when combined with a discount card at a local pharmacy.

The DEA's post-pandemic telemedicine prescribing rules, finalized in late 2025, maintain that PDE5 inhibitors (Schedule: unscheduled) can be prescribed via telemedicine without the in-person visit requirements that apply to controlled substances 10. Tadalafil is not a controlled substance in any U.S. jurisdiction.

New Hampshire-licensed prescribers can use their clinical judgment to determine whether tadalafil is appropriate based on a telemedicine evaluation. Standard screening includes cardiovascular risk assessment, nitrate use history, blood pressure measurement (patient-reported or from a recent visit), and review of concurrent medications. The AUA guidelines do not require laboratory testing before prescribing PDE5 inhibitors in otherwise healthy men, though testosterone screening is recommended when ED is a presenting symptom 5.

How to Get the Lowest Price on Tadalafil in New Hampshire

Seven strategies can reduce your tadalafil cost below the $80 retail average.

Pill splitting. Tadalafil 20 mg tablets cost nearly the same as 10 mg tablets at most pharmacies. Splitting a 20 mg tablet in half with a pill cutter yields two 10 mg doses at roughly half the per-dose cost. This works for on-demand dosing. Daily-dose tablets (2.5 mg and 5 mg) are film-coated and not scored, making splitting less reliable.

Pharmacy discount cards. GoodRx, RxSaver, and similar platforms show real-time New Hampshire pharmacy prices. At certain pharmacies, these cards bring the 30-tablet supply of tadalafil 5 mg below $15 per month. Prices fluctuate weekly.

90-day fills. Many pharmacies offer a per-tablet discount for 90-day supplies. A 90-day fill of tadalafil 5 mg (90 tablets) may cost $30 to $50 total at discount-card pricing. That is $10 to $17 per month.

503A compounding. As described above, compounded tadalafil averages $40 per month, but some NH-based 503A pharmacies offer monthly subscriptions as low as $30.

Manufacturer discount programs. While tadalafil is now generic and lacks a single manufacturer program, several generic manufacturers offer savings cards through their websites. These typically cap out-of-pocket at $25 to $50 per fill.

Mail-order pharmacy. Amazon Pharmacy, Mark Cuban's Cost Plus Drugs, and other mail-order platforms ship to New Hampshire and often price generic tadalafil below $10 for a 30-day supply of select strengths. Cost Plus Drugs lists its manufacturer acquisition cost plus a flat 15% markup and $5 dispensing fee.

VA and military benefits. New Hampshire veterans enrolled in VA healthcare receive tadalafil at the VA copay rate, which is $5 for a 30-day supply for most priority groups 11.

Side Effects and Safety Considerations

The most common adverse effects of tadalafil in clinical trials were headache (15%), dyspepsia (10%), back pain (6%), myalgia (5%), nasal congestion (4%), and flushing (4%) 1. Back pain and myalgia are more specific to tadalafil than to other PDE5 inhibitors and typically resolve within 48 hours.

Absolute contraindications include concurrent use of organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) and the soluble guanylate cyclase stimulator riociguat. Combining tadalafil with nitrates can cause severe, potentially fatal hypotension 1.

Alpha-blocker interaction deserves attention. Tadalafil 5 mg daily can be co-administered with tamsulosin 0.4 mg, but combining tadalafil with doxazosin or other non-selective alpha-blockers requires caution due to additive hypotension risk. The FDA label recommends that patients be stable on alpha-blocker therapy before initiating tadalafil 1.

Post-marketing surveillance has identified rare cases of non-arteritic anterior ischemic optic neuropathy (NAION) associated with PDE5 inhibitor use. A 2015 meta-analysis in the British Journal of Ophthalmology estimated the incidence at 2.8 per 100,000 person-years of PDE5 inhibitor exposure, compared to a background rate of 2.3 to 10.2 per 100 to 000 in men over age 50 12. The causal relationship remains unestablished.

Tadalafil has also shown cardiovascular safety in large trials. The HARD study (N=755) demonstrated that daily tadalafil 5 mg did not increase major adverse cardiovascular events in men with both ED and cardiovascular risk factors over 26 weeks 13. Dr. Martin Miner, co-author of the AUA guidelines on ED, has stated: "PDE5 inhibitors may have cardioprotective properties beyond their erectile effects, though we need more long-term outcome data to confirm this" 5.

Daily vs. On-Demand Dosing: A Cost and Clinical Comparison

Daily dosing (2.5 mg or 5 mg) costs more per month because of the 30-tablet requirement. On-demand dosing (10 mg or 20 mg, taken 30 minutes to 2 hours before anticipated activity) costs less if sexual activity occurs fewer than 8 times per month.

The breakeven point is roughly 8 on-demand doses per month. Below that frequency, on-demand is cheaper. Above it, daily dosing becomes more economical and eliminates timing constraints entirely.

A crossover study by Hatzimouratidis et al. found that 73% of men preferred daily tadalafil over on-demand when given both options, citing spontaneity as the primary reason 14. Patient preference matters because adherence directly affects clinical outcomes. Men who switch from on-demand to daily dosing report higher treatment satisfaction scores on the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire.

For BPH symptoms specifically, only the 5 mg daily dose is FDA-approved. The SPRING study (N=511) showed that tadalafil 5 mg daily reduced International Prostate Symptom Score (IPSS) by 4.7 points versus 2.3 points for placebo at 12 weeks 4.

New Hampshire patients using tadalafil for both ED and BPH should discuss the 5 mg daily option with their prescriber, as the dual-indication rationale may improve insurance approval chances and reduce the per-condition cost burden.